Cardiff Oncology, Inc. Annual Operating Lease, Payments in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Cardiff Oncology, Inc. annual/quarterly Operating Lease, Payments history and growth rate from 2019 to 2023.
  • Cardiff Oncology, Inc. Operating Lease, Payments for the quarter ending June 30, 2023 was $183K, a 1.67% increase year-over-year.
  • Cardiff Oncology, Inc. Operating Lease, Payments for the twelve months ending June 30, 2023 was $730K, a 1.96% increase year-over-year.
  • Cardiff Oncology, Inc. annual Operating Lease, Payments for 2023 was $737K, a 20.4% increase from 2022.
  • Cardiff Oncology, Inc. annual Operating Lease, Payments for 2022 was $612K, a 35.5% decline from 2021.
  • Cardiff Oncology, Inc. annual Operating Lease, Payments for 2021 was $949K, a 0.53% increase from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $737K +$125K +20.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 $612K -$337K -35.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 $949K +$5K +0.53% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-02
2020 $944K +$27.2K +2.97% Jan 1, 2020 Dec 31, 2020 10-K 2022-02-24
2019 $917K Jan 1, 2019 Dec 31, 2019 10-K 2021-02-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.